You are currently browsing the archives for 27 February 2018.
Displaying 1 entry.

CTC counting can determine lung cancer aggressiveness.

Dr Fiona Blackhall, joint author and lung malignancy clinician The Christie in Manchester, said: Our research displays a new way to monitor what sort of patient’s lung malignancy is giving an answer to treatment and regulate how intense it is. We need to test our results in more patients but now, if our results are confirmed, there is currently the potential to tailor remedies to individual sufferers and find new methods to treat the disease. Around 50 per cent of patients do not react to existing treatment but could be exposed to the side results that accompany some of these treatments. New drugs are in the pipeline to treat lung cancer, particularly even more tailored treatments that can focus on the genetic faults in lung cancer.